ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
Aim. To analyze the results of 5-year follow-up of the paroxysmal atrial fibrillation patients (PAF) taking antiarrhythmic therapy (AAT)Material and methods. Patients (n=500) were selected to 11 groups: I — healthy, II — controls, III-XI — PAF taking AAT. The baseline parameters of heart rate variab...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2018-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2836 |
| _version_ | 1797856848181723136 |
|---|---|
| author | T. A. Rybakova V. V. Stolyarova M. G. Nazarkina N. Yu. Leschankina |
| author_facet | T. A. Rybakova V. V. Stolyarova M. G. Nazarkina N. Yu. Leschankina |
| author_sort | T. A. Rybakova |
| collection | DOAJ |
| description | Aim. To analyze the results of 5-year follow-up of the paroxysmal atrial fibrillation patients (PAF) taking antiarrhythmic therapy (AAT)Material and methods. Patients (n=500) were selected to 11 groups: I — healthy, II — controls, III-XI — PAF taking AAT. The baseline parameters of heart rate variability (HRV) were assessed during 5-year follow-up.Results. Decrease of SDNN does 1,9 times increase the risk of AF development during the first 3 months from preventive AAT start. Decrease of RMSSD does 3,9 times increase the risk of AF during the first 2 weeks, and 1,9 times — 3 months; decrease of Delta X increases the risk of AF 3,9 times during 2 weeks, 2 times — during 3 months, 1,4 times — during 6 months, 1,3 times — during 12 months and 3 years. Increase of Amo does 1,8 times increase the risk of AF during first 3 months. If there was baseline decrease of Delta X and RMSSD, then within 2 weeks the AF paroxysm developed in 7,9% patients, and in 3 months — 15,9% patients. With the decrease of Delta X and RMSSD, in combination with low SDNN, the probability of sinus rhythm retention during 1 year is 51,2%.Conclusion. PAF patients taking preventive AAT demand for ECG assessment of HRV parameters no less than once per 3 months. |
| first_indexed | 2024-04-09T20:47:16Z |
| format | Article |
| id | doaj.art-e8b8c67bded44d8ba8f299c329a33196 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:47:16Z |
| publishDate | 2018-08-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-e8b8c67bded44d8ba8f299c329a331962023-03-29T21:23:30Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202018-08-0107677210.15829/1560-4071-2018-7-67-722431ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICST. A. Rybakova0V. V. Stolyarova1M. G. Nazarkina2N. Yu. Leschankina3National Research Mordovskiy State University n. a. Ogarev N. P.National Research Mordovskiy State University n. a. Ogarev N. P.National Research Mordovskiy State University n. a. Ogarev N. P.National Research Mordovskiy State University n. a. Ogarev N. P.Aim. To analyze the results of 5-year follow-up of the paroxysmal atrial fibrillation patients (PAF) taking antiarrhythmic therapy (AAT)Material and methods. Patients (n=500) were selected to 11 groups: I — healthy, II — controls, III-XI — PAF taking AAT. The baseline parameters of heart rate variability (HRV) were assessed during 5-year follow-up.Results. Decrease of SDNN does 1,9 times increase the risk of AF development during the first 3 months from preventive AAT start. Decrease of RMSSD does 3,9 times increase the risk of AF during the first 2 weeks, and 1,9 times — 3 months; decrease of Delta X increases the risk of AF 3,9 times during 2 weeks, 2 times — during 3 months, 1,4 times — during 6 months, 1,3 times — during 12 months and 3 years. Increase of Amo does 1,8 times increase the risk of AF during first 3 months. If there was baseline decrease of Delta X and RMSSD, then within 2 weeks the AF paroxysm developed in 7,9% patients, and in 3 months — 15,9% patients. With the decrease of Delta X and RMSSD, in combination with low SDNN, the probability of sinus rhythm retention during 1 year is 51,2%.Conclusion. PAF patients taking preventive AAT demand for ECG assessment of HRV parameters no less than once per 3 months.https://russjcardiol.elpub.ru/jour/article/view/2836heart rate variabilityatrial fibrillationantiarrhythmic therapy |
| spellingShingle | T. A. Rybakova V. V. Stolyarova M. G. Nazarkina N. Yu. Leschankina ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS Российский кардиологический журнал heart rate variability atrial fibrillation antiarrhythmic therapy |
| title | ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS |
| title_full | ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS |
| title_fullStr | ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS |
| title_full_unstemmed | ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS |
| title_short | ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS |
| title_sort | analysis of the results of five year patients follow up in paroxysmal atrial fibrillation treated with antiarrhythmics |
| topic | heart rate variability atrial fibrillation antiarrhythmic therapy |
| url | https://russjcardiol.elpub.ru/jour/article/view/2836 |
| work_keys_str_mv | AT tarybakova analysisoftheresultsoffiveyearpatientsfollowupinparoxysmalatrialfibrillationtreatedwithantiarrhythmics AT vvstolyarova analysisoftheresultsoffiveyearpatientsfollowupinparoxysmalatrialfibrillationtreatedwithantiarrhythmics AT mgnazarkina analysisoftheresultsoffiveyearpatientsfollowupinparoxysmalatrialfibrillationtreatedwithantiarrhythmics AT nyuleschankina analysisoftheresultsoffiveyearpatientsfollowupinparoxysmalatrialfibrillationtreatedwithantiarrhythmics |